Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2025 results , with sales up 28.8% year on year to ...

Wall Street analysts forecast that Insulet (PODD) will report quarterly earnings of $0.81 per share in its upcoming release, pointing to a year-over-year increase of 11%. It is anticipated that ...

Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy ...

For example, Roche introduced Accu-Chek SmartGuide ... Insulet Corporation (NASDAQ:PODD), based in Acton, Massachusetts, specializes in diabetes management through its innovative Omnipod platform ...

Insulet PODD shares soared 7.2% in the last trading session to close at $264.72. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...

On the other side of ROCE, we have to consider valuation. That's why we have a FREE intrinsic value estimation for PODD on our platform that is definitely worth checking out.